Post Profile






Pimavanserin: Relief from psychosis in dementia, without devastating side-effects

A new kind of antipsychotic has been found to relieve terrifying and disturbing symptoms suffered by millions of people with Alzheimer's disease worldwide. New research led by the University of Exeter Medical School, and published today in Lancet Neurology found that pimavanserin significantly improves psychosis symptoms in people with the condition, without the devastating side-effects of currently-used antipsychotics.
read more

share

Related Posts


Potential solution for side effect of Alzheimer's immunotherapy treatment

Academics / General Science : Science Codex

It is estimated that 46.8 million people worldwide are living with dementia, with Alzheimer's disease the most common form. Now researchers from the University of Southampton have discovered a possible solution for side effects seen...

The power of music may decrease the need for medication in dementia patients: Study

Health : Bel Marra Health

Suffering from Alzheimer’s or other kinds of dementia can be a disorienting and anxious experience. But according to a new study, personalized music made these symptoms easier to cope with. Medications such as antipsychotic and anti...

Global experts seek to end damaging dementia psychosis cycle

Health : EurekAlert: Health

(University of Exeter) A new research report calls for a change in approach in the treatment of psychosis in dementia, to find alternatives to highly damaging antipsychotics.

Pimavanserin: Relief from psychosis in dementia, without devastating side-effects

Health / Aging : ScienceDaily: Healthy Aging

New research has found that pimavanserin significantly improves psychosis symptoms in people with Alzheimer's disease, without the devastating side-effects of currently used antipsychotics. The research found an even greater benefit...

Pimavanserin: Relief from psychosis in dementia, without devastating side-effects

Academics / Sociology : EurekAlert: Social Behavioral

(University of Exeter) New research led by the University of Exeter Medical School, and published today in Lancet Neurology found that pimavanserin significantly improves psychosis symptoms in people with the condition, without the ...

Comments


Copyright © 2016 Regator, LLC